title: Beta blockers and intravenous roentgen contrast materials: Which risks do exist?
authors.affiliation: Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland; Radiology Laboratory, Department of Clinical Research, University of Bern, Bern, Switzerland. Electronic address: Ingrid.boehm@insel.ch.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Boehm
authors.affiliation: St. John's Medical Center, Tulsa, OK, USA.
authors.forename: John
authors.initials: J
authors.lastname: Morelli
authors.affiliation: Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland.
authors.forename: Knud
authors.initials: K
authors.lastname: Nairz
authors.affiliation: Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland.
authors.forename: Patricia
authors.initials: P
authors.lastname: Silva Hasembank Keller
authors.affiliation: Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland; Radiology Laboratory, Department of Clinical Research, University of Bern, Bern, Switzerland.
authors.forename: Johannes T
authors.initials: JT
authors.lastname: Heverhagen
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000707:Anaphylaxis / Q000139:chemically induced*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D018570:Risk Assessment
chemical_list: D000319:Adrenergic beta-Antagonists; D003287:Contrast Media
keywords: Beta blockers; Gadolinium-based contrast agents; Iodinated contrast media; Prophylaxis; Risk